期刊文献+

角化棘皮瘤的临床与病理分析 被引量:4

Clinical and pathological features of keratoacanthoma
下载PDF
导出
摘要 目的:探讨角化棘皮瘤的临床、病理学特征、恶性程度及预后。方法:收集18例角化棘皮瘤患者资料,观察和分析其临床和组织病理学特征,并通过免疫组化方法分析其p53、bcl-2及P-gp的表达。结果:角化棘皮瘤的典型皮损为边界清楚的半球状隆起,中央形成“火山口”样溃疡,其中充满角化物质;组织病理以表皮向真皮内凹陷呈“火山口”状,其中充满角化物质,两侧的上皮细胞形成“唇缘”包绕瘤体为特征;首选手术治疗、长期随访。18例角化棘皮瘤中p53阳性表达明显高于正常对照组(P<0.05),bcl-2、P-gp阳性表达与正常对照组相比没有显著性差异(P>0.05)。结论:角化棘皮瘤为低恶性的皮肤肿瘤,有特殊的临床及组织病理特点,免疫组化有助于判断肿瘤的发病、恶性程度及预后。 Objective:To study the clinical and pathological features,malignancy and prognosis of keratoacanthoma(KA).Methotis: Eighteen patients with KA were collected, and their clinical features were analyzed with pathological aspects observed by immunohistochemical SP techniques.Results:The typical lesion of KA is a hemispheric,dome-shaped,skin-colored nodule in which there is a smooth crater filled with a central keratin plug.Histological examination showed a crater filled with eosinophilic keratin.A "lip"formed by invagination of epidermis surrounds the keratin-filled crater.Wide excision of the lesions is the first choice for the treatment of KA. The expression levels of p53 was higher than controls (P〈0.05).No statistical significance were found on the expression of bcl-2 and P-gp.Conclusions:KA is a skin malignant tumor with it's typical clinical and pathological features. The diagnosis ,malignancy and prognosis of KA can be confirmed by immunohistochemical staining.
作者 单葵 李桂明
出处 《重庆医科大学学报》 CAS CSCD 2007年第4期416-418,共3页 Journal of Chongqing Medical University
关键词 角化棘皮瘤 临床分析 病理特征 P53 BCL-2 P—gP Keratoacanthoma Clinical analysis Pathological feature p53 bcl-2 P-gp
  • 相关文献

参考文献11

  • 1赵辩.临床皮肤病学[M](第3版)[M].南京:江苏科学技术出版社,2001.613-618.
  • 2丁海峰,赵天恩,卢宪梅.角化棘皮瘤研究进展[J].中国麻风皮肤病杂志,2005,21(6):465-467. 被引量:17
  • 3Sanders S,Busam KJ,Halpern AC,et al.Intralesional corticosteroid treatment of multiple eruptive keratoacanthomas:cade report and review of a controversial therapy[J].Dermatol Surg,2002;28:954-958.
  • 4Di Lemia V,Ricci C,Albertini G.Spontaneous regression of keratoacanthoma can be promoted by topical treatment with imiquimod cream[J].J Eur Acad Dennatol Venereol,2004; 18:626-629.
  • 5Cribier B,ash P-H,Grosshans E.Differentiating squamous cell carcinoma from keratoacanthoma using histopathological criteria:is it possible A study of 396 cases[J].Dermatology,1999;199:208-212.
  • 6Biesterfeld S,Josef J.Differential diagnosis of keratoacanthoma and squamous cell carcinoma of the epidermis by MIB-1 immunohistometry[J].Anticancer Res,2002;22:3019-3023.
  • 7Melendez ND,Smoller BR,Morgan M.VCAM (CD-106) and ICAM(CD-54) adhesion molecules distinguish keratoacanthomas from cutaneous squamous cell carcinomas[J].Mod Pathol,2003; 16:8-13.
  • 8Tran T-A,Ross JS,Sheehan CE,et al.Comparison of oncostatin M expression in keratoacanthoma and squamous cell carcinoma[J].Mod Pathol,2000; 12:427-432.
  • 9李树发,尹浩然,张俊,燕敏,朱正纲,林言箴.顺铂杀伤原代胃癌细胞效应与P-糖蛋白和谷胱甘肽S转移酶表达的关系[J].中国现代医学杂志,2003,13(12):23-25. 被引量:3
  • 10Batinac T,Zamolo G,Coklo M,et al.Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma[J].Pathol Res Pract,2006;202(8):599-607.

二级参考文献22

  • 1Chu DH, Hale EK, Robins P. Generalized eruptive keratoacanthoma of grzybowski. J Drugs Dermatol 2003;3:318-319.
  • 2Mangas C, Bielsa I, Ribera M, et al. A case of multiple keratoacanthoma centrifugum marginatum. Dermatol Surg 2034;30:803-806.
  • 3Cribier B, asch P-H, Grosshans E. Differentiating squamous cell carcinoma from keratoacanthoma using histopathological criteria: is it possible? A study of 396 cases. Dermatology 1999;199:208-212.
  • 4Biesterfeld S, Josef J. Differential diagnqsis of keratoacanthoma and squamous cell carcinoma of the epidermis by MIB-1 immunohistometry. Anticancer Res 2002;22:3019-3023.
  • 5Melendez ND, Smoller BR, Morgan M. VCAM (CD-106) and ICAM(CD-54) adhesion molecules distinguish keratoacanthomas from cutaneous squamous cell carcinomas. Mod Pathol 2003; 16:8-13.
  • 6Tran T-A, Ross JS, Sheehan CE, et al. Comparison of oncostatin M expression in keratoacanthoma and squamous cell carcinoma. Mod Pathol 2000;12:427-432.
  • 7Takeda H, Kondo S. Differences between squamous cell carcinoma and keratoacanthoma in angiotensin type-1 receptor expression. Am J Pathol 2001;158:1633-1637.
  • 8Mukunyadzi P, Sanderson RD, Fan C-Y, et al. The level of syndecan-1 expression is a distinguishing feature in behavior between keratoacanthoma and invasive cutaneous squamous cell carcinoma. ModPathol 2002;15:45-49.
  • 9Machin P, Catasus L, Pons C, et al. Microsatellite instability and immuneostaining for MSH-2 and MLH-1 in cutaneous and internal tumors from patients with the Muir-Torte syndrome. J Cutan Pathol 2002;29:415-420.
  • 10Godbolt AM, Sullivan JJ, Weedon D. Keratoacanthoma with perineural invasion: a report of 40 cases. Australas J Dermatol 2001;42:168-171.

共引文献87

同被引文献22

  • 1丁海峰,赵天恩,卢宪梅.角化棘皮瘤研究进展[J].中国麻风皮肤病杂志,2005,21(6):465-467. 被引量:17
  • 2薛飞,王天友,吴昆旻,周玫,王秋萍.鼻背部角化棘皮瘤1例[J].中国耳鼻咽喉颅底外科杂志,2005,11(3):132-132. 被引量:1
  • 3陈健,鲁洁琼.角化棘皮瘤及癌变15例临床病理分析[J].浙江医学,2005,27(6):442-443. 被引量:3
  • 4Sander S, Busam KJ, Halpern AC, et al. Intralesional corticosteroid treatment of multiple eruptive keratoacanthomas:ease report and review of a controversal therapy[J].Dermatol Surg, 2002,28(10): 954-958.
  • 5Di Lemia V, Rieei C, Albertini G. Spontaneous regression of keratoacanthoma can be promoted by topical treatment with imiquimod cream[J]. J Eur Acad Dermatol Venereol, 2004,18(5):626-629.
  • 6Mngas C, Bielsa I, Ribera M, et al. A case of multiple keratoacanthoma centrifugum marginatum[J].Dermatol Surg, 2004, 30(5):803-806.
  • 7Sanchez Yus E, Simon P, Requena L, et al. Solitary keratoacanthoma..a self -healingproliferation that frequently becomes maliguant[J].Am J Dermatopathol, 2000,22(4) : 305-310.
  • 8Kossard S, Tan KB, Choy C, et al, Keratoacanthoma and in fundibulocystic squamous cell carcinoma [J].Am J Dermatopathol 2008,30(2) : 127-134.
  • 9Karaa A, Khachemoune A. Keratoaeanthoma: a tumor in search of a classification [ J ]. Int J Dermatol, 2007, 46 ( 7 ) : 671 - 678.
  • 10Beham A, Regauer S, Soyer HP, et al. Keratoaeanthoma : a clinically distinct variant of well differentiated squamous cell car- cinoma[J]. Adv Anat Pathol, 1998, 5(5) : 269 -280.

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部